Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/21/2014 | WO2014102596A3 Cyclic cationic peptides with antibmicrobial activity |
08/21/2014 | WO2014088935A3 Compositions of beta-mannanase and methods of use |
08/21/2014 | WO2014071405A3 Long-acting single-chain insulin analogues |
08/21/2014 | US20140237689 Metabolic regulators |
08/21/2014 | US20140237632 Rapidly maturing fluroscent proteins and methods for using the same |
08/21/2014 | US20140237631 Neurovirulent Strain of the West Nile Virus and Uses Thereof |
08/21/2014 | US20140236070 Linear expression cassettes and uses thereof |
08/21/2014 | US20140235836 Immunologic Constructs and Methods |
08/21/2014 | US20140235832 Rank ligand polypeptides |
08/21/2014 | US20140235829 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha |
08/21/2014 | US20140235826 Optically-based stimulation of target cells and modifications thereto |
08/21/2014 | US20140235823 Fusion protein containing a single-stranded dna binding protein and methods for expression and purification of the same |
08/21/2014 | US20140235820 METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY |
08/21/2014 | US20140235789 Solid phase peptide synthesis via side chain attachment |
08/21/2014 | US20140235564 Methods for treating neural cell swelling |
08/21/2014 | US20140235557 Small Efficient Cell Penetrating Peptides Derived From The Scorpion Toxin Maurocalcine |
08/21/2014 | US20140235554 Ophthalmic formulation derived from silk protein |
08/21/2014 | US20140235549 Stabilized polypeptides as regulators of rab gtpase function |
08/21/2014 | US20140235538 Stabilized Insulin-like Growth Factor Polypeptides |
08/21/2014 | US20140235537 N-glycosylated insulin analogues |
08/21/2014 | US20140235535 Engineered polypeptides having enhanced duration of action with reduced immunogenicity |
08/21/2014 | US20140235534 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
08/21/2014 | US20140235467 Protease-Resistant Systems for Polypeptide Display and Methods of Making and Using Thereof |
08/21/2014 | US20140234962 Ligands Modified by Circular Permutation as Agonists and Antagonists |
08/21/2014 | US20140234948 Molecular motor |
08/21/2014 | US20140234945 Transthyretin variants |
08/21/2014 | US20140234943 Viruses Lacking Epithelial Cell Receptor Entry |
08/21/2014 | US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues |
08/21/2014 | US20140234901 Method for Secretory Production of Protein |
08/21/2014 | US20140234900 Methods for the release of virus-like particles |
08/21/2014 | US20140234868 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medical-plant derived ligand |
08/21/2014 | US20140234570 Method of producing flat cocoon product and flat cocoon product |
08/21/2014 | US20140234401 Method of treating inflammation using human immunosuppressive protein |
08/21/2014 | US20140234363 Polypeptides from non-typeable haemophilus influenzae |
08/21/2014 | US20140234362 Defensin-antigen fusion proteins |
08/21/2014 | US20140234361 Novel expression vectors and uses thereof |
08/21/2014 | US20140234359 Plant viral vaccines and therapeutics |
08/21/2014 | US20140234357 H5 proteins of h5n1 influenza virus for use as a medicament |
08/21/2014 | US20140234356 Influenza antigen delivery vectors and constructs |
08/21/2014 | US20140234355 Infectious clones of torque teno virus |
08/21/2014 | US20140234352 B7-h3 and b7-h4, novel immunoregulatory molecules |
08/21/2014 | US20140234348 Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens |
08/21/2014 | US20140234334 Peptides and related molecules that bind to tall-1 |
08/21/2014 | US20140234326 Method for decreasing radioresistance and growth, metastasis and infiltration of cancer cells through regulating expression or activity of tm4sf4 in non-small cell lung cancer |
08/21/2014 | US20140234316 Vaccibodies targeted to cross-presenting dendritic cells |
08/21/2014 | US20140234311 Albumin variants |
08/21/2014 | US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections |
08/21/2014 | US20140234309 Antibody-mediated transduction of heat shock proteins into living cells |
08/21/2014 | US20140234306 Agent and Method for Reducing Inflammatory Markers |
08/21/2014 | US20140234292 Process for Producing a Plasma Protein-Containing Medicament |
08/21/2014 | US20140234291 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
08/21/2014 | US20140234274 Directed Evolution and In Vitro Panning of Virus Vectors |
08/21/2014 | US20140234255 Microdystrophin peptides and methods for treating muscular dystrophy using the same |
08/21/2014 | US20140234221 Antigen-binding proteins comprising recombinant protein scaffolds |
08/21/2014 | DE112012004586T5 Pflanzen mit erhöhter Toleranz gegenüber Herbiziden Plants with increased tolerance to herbicides |
08/21/2014 | CA2807162A1 Solid phase peptide synthesis via side chain attachment |
08/20/2014 | EP2767829A1 A method for identifying bitter principles and bitter-modulating principles |
08/20/2014 | EP2767547A1 Proteinaceous protease inhibitor and protein solution and detergent composition containing it |
08/20/2014 | EP2767546A1 Lipoprotein complexes and manufacturing and uses therof |
08/20/2014 | EP2767545A1 Method for producing peptide |
08/20/2014 | EP2767290A1 Amino acid sequences for controlling pathogens |
08/20/2014 | EP2767161A1 Method for generating an non-human animal homozygous for a genetic modification |
08/20/2014 | EP2766484A2 Regulation of receptor expression through delivery of artificial transcription factors |
08/20/2014 | EP2766391A1 Canine/feline cd20 binding epitope and compositions for binding thereto |
08/20/2014 | EP2766390A1 Compositions and methods for treating heart failure |
08/20/2014 | EP2766389A2 Gene cluster for biosynthesis of griselimycin and methylgriselimycin |
08/20/2014 | EP2766388A1 Peptides derived from campylobacter jejuni and their use in vaccination |
08/20/2014 | EP2766387A1 Products useful for the treatment of malignant neoplasms of the human nervous system |
08/20/2014 | EP2766386A1 Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
08/20/2014 | EP2766385A2 Cmv antigens and uses thereof |
08/20/2014 | EP2766384A1 Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response |
08/20/2014 | EP2766034A1 Zymogen activators |
08/19/2014 | US8809653 Inbred corn line BC110 |
08/19/2014 | US8809652 Inbred corn line LM3 |
08/19/2014 | US8809651 Inbred corn line BB93 |
08/19/2014 | US8809650 Maize variety inbred PH1MHD |
08/19/2014 | US8809630 Polynucleotides and polypeptides in plants |
08/19/2014 | US8809516 Therapeutic compositions |
08/19/2014 | US8809511 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
08/19/2014 | US8809510 Method for purification of complement factor H |
08/19/2014 | US8809504 Inhibitor which is deactivatable by a reagent produced by a target cell |
08/19/2014 | US8809503 Optimized Fc variants and methods for their generation |
08/19/2014 | US8809501 Nucleophilic catalysts for oxime linkage |
08/19/2014 | US8809500 Complexes comprising mammalian raptor polypeptide and mammalian mTOR polypeptide |
08/19/2014 | US8809499 Fusion protein of human fibroblast growth factor-21 and exendin-4 |
08/19/2014 | US8809497 Compounds and methods for the treatment of vascular disease |
08/19/2014 | US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
08/19/2014 | US8809279 Peptides that are modulators of the protein TRF2 and compositions containing same |
08/19/2014 | US8809271 Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
08/19/2014 | US8809269 Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
08/19/2014 | US8809259 Charged nutritive proteins and methods |
08/19/2014 | US8809258 Method for producing peptide |
08/19/2014 | US8809257 Compositions and methods for promoting wound healing and tissue regeneration |
08/19/2014 | US8809060 Ethanol-resistant yeast gene, and use thereof |
08/19/2014 | US8809058 Helper virus-free AAV production |
08/19/2014 | US8809051 Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom |
08/19/2014 | US8809047 Herpes simplex virus vaccines |
08/19/2014 | US8809011 HIFα hydroxylation assay |
08/19/2014 | US8809004 Detection of feline immunodeficiency virus |
08/19/2014 | US8809001 High throughput assays for inhibitors and activators of PAQR receptors |